Anne-benedicte B. Modeste-Duval

Rouen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 22, 2025

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.

Efficacy and Tolerability of Tebentafusp in Metastatic Uveal Melanoma: A Real-life Retrospective Multicentre Study.

Journal: Acta dermato-venereologica

Published: August 06, 2024

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Increased risk of cutaneous squamous cell carcinomas in patients with Sézary syndrome: A nationwide multicenter retrospective study.

Journal: Journal of the American Academy of Dermatology

Published: July 17, 2024

Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.

Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 06, 2023

Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature.

Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature.

Journal: Melanoma research

Published: March 30, 2023

Survival in adult patients with BRAFV600 mutation-positive advanced melanoma: a noninterventional ambispective study of patients with cobimetinib combined with vemurafenib during the French early access program: MELANIS study.

Survival in adult patients with BRAFV600 mutation-positive advanced melanoma: a noninterventional ambispective study of patients with cobimetinib combined with vemurafenib during the French early access program: MELANIS study.

Journal: Melanoma research

Published: May 31, 2022

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.

Journal: Cancers

Published: June 06, 2021

Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.

Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.

Journal: Frontiers in immunology

Published: March 01, 2021

Intralesional rituximab treatment for atypical refractory granuloma faciale.

Intralesional rituximab treatment for atypical refractory granuloma faciale.

Journal: Annales de dermatologie et de venereologie

Published: February 04, 2021

Panniculitis in a Woman With Opportunistic Pulmonary Coinfection by Pneumocystis jirovecii and Cryptococcus neoformans: 18F-FDG PET/CT Revealing the Infection and Assessing Treatment Response.

Panniculitis in a Woman With Opportunistic Pulmonary Coinfection by Pneumocystis jirovecii and Cryptococcus neoformans: 18F-FDG PET/CT Revealing the Infection and Assessing Treatment Response.

Journal: Clinical nuclear medicine

Published: December 14, 2020

Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.

Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.

Journal: International journal of cancer

Published: August 20, 2020

Anti-PD-1 induced collagenous colitis in metastatic melanoma: a rare severe adverse event.

Anti-PD-1 induced collagenous colitis in metastatic melanoma: a rare severe adverse event.

Journal: Melanoma research

Published: May 15, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026